2024-09-11 Sale Axsome Therapeutics, Inc. AXSM
director $91.31 $1.01M +2.92% 2021-11-17 Purchase Axsome Therapeutics, Inc. AXSM
director $34.52 $113,922 +7% 2019-05-23 Purchase Axsome Therapeutics, Inc. AXSM
director $22.33 $78,155 +40.71% 2012-03-14 Purchase Plus Therapeutics, Inc. PSTV
Chief Financial Officer $2.55 $25,494 +10.32% 2011-08-12 Purchase Plus Therapeutics, Inc. PSTV
Chief Financial Officer $3.12 $20,290 -18.6% 2010-05-21 Purchase Plus Therapeutics, Inc. PSTV
Chief Financial Officer $4.29 $25,741 +17.59% 2008-08-12 Purchase Plus Therapeutics, Inc. PSTV
Chief Financial Officer $6.69 $100,310 -49.47% 2006-09-05 Purchase Plus Therapeutics, Inc. PSTV
Chief Financial Officer $5.08 $9,393 +15.54% 2006-09-01 Purchase Plus Therapeutics, Inc. PSTV
Chief Financial Officer $5.31 $8,229 +9.51% 2006-08-31 Purchase Plus Therapeutics, Inc. PSTV
Chief Financial Officer $5.48 $4,113 +10.13% 2006-08-30 Purchase Plus Therapeutics, Inc. PSTV
Chief Financial Officer $5.42 $4,068 +8.97% 2006-08-29 Purchase Plus Therapeutics, Inc. PSTV
Chief Financial Officer $5.21 $4,169 +10.09% 2006-08-28 Purchase Plus Therapeutics, Inc. PSTV
Chief Financial Officer $5.20 $4,158 +10.51% 2006-08-25 Purchase Plus Therapeutics, Inc. PSTV
Chief Financial Officer $4.99 $3,994 +18.46% 2006-08-24 Purchase Plus Therapeutics, Inc. PSTV
Chief Financial Officer $4.62 $3,925 +21.67% 2006-08-23 Purchase Plus Therapeutics, Inc. PSTV
Chief Financial Officer $4.28 $3,638 +24.26% 2006-08-22 Purchase Plus Therapeutics, Inc. PSTV
Chief Financial Officer $4.33 $6,997 +40.05% 2006-08-21 Purchase Plus Therapeutics, Inc. PSTV
Chief Financial Officer $4.52 $3,991 +32.73% 2004-11-18 Purchase Plus Therapeutics, Inc. PSTV
Chief Financial Officer $3.00 $150,000 -3.28%